Neuropediatrics 2024; 55(03): 166-170
DOI: 10.1055/s-0044-1779619
Original Article

STAC3-related myopathy: A Report of a Cohort of Seven Saudi Arabian Patients

1   Department of Neuroscience, King Fahd Specialist Hospital, Dammam, Saudi Arabia
,
1   Department of Neuroscience, King Fahd Specialist Hospital, Dammam, Saudi Arabia
2   Department of Pediatric Neurology and Metabolic Division, Kasr AlAiny School of Medicine, Cairo University, Cairo, Egypt
,
Fatima Alfaraj
3   Pulmonary Division, Department of Internal Medicine, King Fahd Specialist Hospital, Dammam, Saudi Arabia
,
Patrick G. Burgon
4   Department of Chemistry and Earth Sciences, College of Arts and Sciences, Qatar University, Doha, State of Qatar
,
Shahid Bashir
1   Department of Neuroscience, King Fahd Specialist Hospital, Dammam, Saudi Arabia
,
Fouad Alghamdi
1   Department of Neuroscience, King Fahd Specialist Hospital, Dammam, Saudi Arabia
› Author Affiliations

Abstract

Aim The study aims to review all the genetically confirmed STAC3-related myopathy being followed in a single center in the Eastern Province of Saudi Arabia.

Methodology A retrospective review of all genetically confirmed STAC3-related myopathy followed in our clinic has been conducted.

Results 7 patients with STAC3-related myopathy have been found in our cohort, with all the patients presenting with infantile hypotonia, myopathic facies, and muscle weakness in the first year of life. Feeding difficulties and failure to thrive were found in all patients except one who died during the neonatal period. Respiratory muscle involvement was also found in 5 out of 6 formally tested patients while cleft palate was found in 5 patients.

Conclusion STAC3-related myopathy is a relatively rare, malignant hyperthermia (MH)--causing muscle disease described in specific, highly consanguineous populations. Making the diagnosis in myopathic patients with cleft palate preoperatively can prevent MH-induced, anesthesia-related perioperative complications.



Publication History

Received: 24 December 2023

Accepted: 10 January 2024

Article published online:
16 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Stamm DS, Aylsworth AS, Stajich JM. et al. Native American myopathy: congenital myopathy with cleft palate, skeletal anomalies, and susceptibility to malignant hyperthermia. Am J Med Genet A 2008; 146A (14) 1832-1841
  • 2 Zaharieva IT, Sarkozy A, Munot P. et al. STAC3 variants cause a congenital myopathy with distinctive dysmorphic features and malignant hyperthermia susceptibility. Hum Mutat 2018; 39 (12) 1980-1994
  • 3 Bailey AG, Bloch EC. Malignant hyperthermia in a three-month-old American Indian infant. Anesth Analg 1987; 66 (10) 1043-1045
  • 4 Gromand M, Gueguen P, Pervillé A. et al. STAC3 related congenital myopathy: a case series of seven Comorian patients. Eur J Med Genet 2022; 65 (10) 104598
  • 5 Grzybowski M, Schänzer A, Pepler A, Heller C, Neubauer BA, Hahn A. Novel STAC3 mutations in the first non-Amerindian patient with Native American myopathy. Neuropediatrics 2017; 48 (06) 451-455
  • 6 Murtazina A, Demina N, Chausova P, Shchagina O, Borovikov A, Dadali E. The first Russian patient with Native American myopathy. Genes (Basel) 2022; 13 (02) 341
  • 7 Urtizberea JA, Alrohaif H, Gouda SA, Bastaki L. [When all roads lead to Africa…]. Med Sci (Paris) 2019; 35 Hors série n° 2: 15-17
  • 8 Telegrafi A, Webb BD, Robbins SM. et al. Moebius Syndrome Research Consortium. Identification of STAC3 variants in non-Native American families with overlapping features of Carey-Fineman-Ziter syndrome and Moebius syndrome. Am J Med Genet A 2017; 173 (10) 2763-2771